Screening for hip dysplasia in congenital muscular torticollis: is physical exam enough? by Elizabeth R. A. Joiner et al.
ORIGINAL CLINICAL ARTICLE
Screening for hip dysplasia in congenital muscular torticollis: is
physical exam enough?
Elizabeth R. A. Joiner • Lindsay M. Andras •
David L. Skaggs
Received: 17 October 2013 / Accepted: 13 February 2014 / Published online: 28 February 2014
 The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract
Purpose An association between congenital muscular
torticollis (CMT) and developmental dysplasia of the hip
(DDH) has been established in the literature; however,
whether the screening of patients with CMT for DDH
requires hip imaging remains controversial. The purpose of
this study is to determine (1) the coexistence rate of DDH
requiring treatment in individuals with CMT and (2) if
physical exam alone is sufficient screening.
Methods A single-center retrospective chart review was
performed among 97 consecutive patients between 1/1/
2003 and 9/1/2012 with CMT who had hip imaging
performed.
Results 12 % (12/97) of patients with CMT had DDH, all
requiring treatment. 75 % (9/12) of the patients with DDH
had an abnormal clinical exam. Of the three patients with
DDH and a normal clinical exam, two patients were pre-
senting for a second opinion after being treated for DDH
prior to evaluation. 90 % (9/10) of patients with DDH at
the time of presentation had an abnormal hip exam. All 12
patients with hip dysplasia were referred for DDH or DDH
with CMT. There were no patients who were referred for
CMT alone that had DDH.
Conclusions In the care of a patient with CMT, it is
important that the clinician remains vigilant about screen-
ing for DDH. An ultrasound or radiograph of the hips
should be strongly considered as part of the evaluation of a
child with CMT.
Level of evidence: IV.
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Introduction
A relationship between congenital muscular torticollis
(CMT) and developmental dysplasia of the hip (DDH) was
first described by Coventry and Harris [1], followed soon
after by the report of a 14.8 % coexistence rate of DDH in
patients with CMT by Iwahara and Ikeda [2]. There have
since been many reports in the literature that confirm this
relationship, although the coexistence rate widely varies
from 0 to 20 % [1–19]. This wide range of coexistence
rates has been largely attributed to differences in methods,
definitions, and diagnostic criteria [7]. Additionally, only a
few studies report the incidence of cases of DDH that
require treatment in patients with CMT. If only such cases
were considered, the incidence rates range from 0 to 8.5 %
[3, 6, 7, 13, 19].
The indications for hip imaging in the setting of CMT
remain controversial. Hummer and MacEwen [12] were the
first to recommend clinical and roentgenographic exami-
nation of both hips in all children with CMT, which was
again recommended in a later study by Morrison and
MacEwen [15]. Tien et al. [7] conducted an ultrasono-
graphic study of the coexistence of CMT and DDH and
recommended that ultrasound imaging of the hip be per-
formed routinely for patients with CMT. von Heideken
et al. [8] also recommend that children with CMT be
evaluated for DDH but did not differentiate between
physical exam and radiographic screening. Most recently,
Kim et al. [6] and Minihane et al. [19] came to the con-
clusion that bilateral hip ultrasound should not be recom-
mended routinely for patients with CMT, given that, in
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their series, all patients with DDH requiring treatment also
had an abnormal clinical hip examination.
There is no consensus on when imaging of the hips is
indicated in patients with CMT. The American Academy of
Pediatrics [20] recommends the screening of newborn
infants using physical examination. While the American
Academy of Pediatrics recommends considering imaging
in addition to physical exam for patients with a breech
presentation or positive family history, it is not recom-
mended for routine screening in cases of CMT. The Pedi-
atric Orthopaedic Society of North America agreed with
these recommendations in their statement regarding current
guidelines for DDH screening. The United States Preven-
tative Services Task Force [22] and the Cochrane Collab-
oration [23] conducted systematic reviews on the literature
regarding screening for DDH in infants and found that the
existing evidence ranges from fair to poor and is insuffi-
cient to give clear and conclusive recommendations for
practice. Additional guidelines exist from the American
College of Radiology [24, 25], but none of these recom-
mendations address routine screening in patients with
CMT.
The purpose of this study is to determine (1) the coex-
istence rate of DDH requiring treatment in patients with the
diagnosis of CMT who have had hip imaging at our
institution and (2) whether there are patients with CMT and
DDH requiring treatment who present with a normal
physical exam of the hip.
Methods
After approval for the study was obtained from our insti-
tutional review board, we identified patients diagnosed
with CMT between 1/1/2003 and 9/1/2012 at our institu-
tion. Patients were excluded if they did not have hip
imaging, or if the torticollis was associated with a neuro-
muscular or syndromic etiology, congenital anomaly, or
ocular problem. Charts were reviewed for the reason for
referral, demographic information, family history, physical
exam findings, imaging results, treatment for DDH (where
applicable), and complications. Descriptive statistics were
calculated for analysis.
Results
Ninety-seven patients met the inclusion criteria, 55 % (53/
97) females and 45 % (44/97) males, with an average age
at presentation of 7.9 months (range 0.3–27.1 months). On
physical exam of the hips, 20 % (19/97) of patients had an
abnormality detected, including asymmetric abduction,
asymmetric skin folds, hip click, positive Galeazzi/Allis,
positive Ortolani, and positive Barlow (see Fig. 1). Seven
patients had two or more of the above positive findings on
physical exam. Ultrasound was the first hip imaging per-
formed in 28/97 (29 %) patients at an average age of
2.5 months (range 0.4–5.9 months). Plain radiographs
were the first hip images performed in 69/97 (71 %)
patients at an average age of 11.2 months (range
2.0–40.2 months). Despite the abnormal hip exam, 10 of
these 19 patients did not have any evidence of hip dysplasia
on imaging.
Of the 97 patients diagnosed with CMT that had hip
imaging available, 12 % (12/97) were found to have hip
dysplasia that required treatment. The rate of patients with
CMT found to have DDH listed by reason for referral may
be seen in Fig. 2. Of the patients who were diagnosed with
DDH, 75 % (9/12) had an abnormal physical exam. Of the
three patients with a normal exam, two patients were being
seen as a second opinion and had a past medical history of
DDH that had already been successfully treated with a
Fig. 1 Abnormal findings on physical exam of the hips in patients
with congenital muscular torticollis (CMT). Used with the permission
of the Children’s Orthopaedic Center, Los Angeles
Fig. 2 Patients with CMT who were found to have DDH, separated
by reason for referral. Used with the permission of the Children’s
Orthopaedic Center, Los Angeles
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Pavlik harness. Only one patient who had a normal phys-
ical exam was diagnosed with DDH at that time. Therefore,
of the patients who had DDH at the time of presentation,
90 % (9/10) had an abnormal hip exam (see Fig. 3). All 12
of the patients with the diagnosis of DDH received treat-
ment, including Pavlik harness only (6), abduction brace
only (1), Pavlik harness followed by abduction brace (1),
closed reduction and adductor tenotomies (2), and open
reduction (2) with acetabular osteotomy (1) (see Fig. 4).
Discussion
Of the 97 patients diagnosed with CMT that had hip
imaging available, 12 % (12/97) were found to have hip
dysplasia that required treatment. This falls within the wide
range of rates previously reported in the literature, 0–20 %
[1–19], but is higher than rates where only cases of DDH
that required treatment were included, 0–8.5 % [3, 6, 7, 13,
19]. The wide variability in coexistence rates had been
largely attributed to differences in methods, definitions,
and diagnostic criteria [7], and this study is no exception.
Additionally, this rate may be higher because we did not
include patients with CMT who did not have hip imaging
available in our system, which may have lowered the rate.
However, one of our goals of the study was to determine
whether there are patients with CMT who require hip
imaging to reveal DDH requiring treatment (versus clinical
exam alone); therefore, we decided to exclude those
patients without imaging. Despite the wide range of
coexistence rates reported in the literature, there is a
growing body of evidence supporting the existence of an
association between CMT and DDH, which is important
for the clinician to be aware of when treating patients with
either of these diagnoses.
Fig. 3 Table showing the rate of true-positive, false-positive, true-
negative, and false-negative physical exam findings using the data
from our series. Of note, this table excludes patients who did not have
hip imaging performed. *Includes two patients who were previously
treated for developmental dysplasia of the hip (DDH) and, at the time
of presentation, had no clinical or radiographic findings suggestive of
DDH. Used with the permission of the Children’s Orthopaedic
Center, Los Angeles





*Presented as second opinion,
previously treated. Used with
the permission of the Children’s
Orthopaedic Center, Los
Angeles
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There is general agreement that patients with CMT
should be screened for DDH [6–8, 12, 15, 19]. However,
there is no consensus as to whether routine screening
should consist of physical exam and imaging of the hips, or
physical exam alone. The most recent studies suggest that
physical exam alone is sufficient screening, given that all
the patients in their series with DDH had an abnormal
clinical hip exam [6, 19]. Of the 12 % of patients with
CMT and DDH, only 75 % (9/12) of our patients with
DDH had an abnormal clinical hip exam. However,
excluding the two patients who were previously treated for
DDH, nine out of ten patients (90 %) with DDH had an
abnormal physical exam. The argument could be made that
adding imaging of the hips to routine screening is unnec-
essary, since the overwhelming majority present with
abnormal physical exam findings. However, there was one
patient in our series who had DDH that required treatment
who did not have any abnormalities on clinical exam of the
hip. Although patients like this may be a rarity, stating that
screening hip imaging in patients with CMT is not neces-
sary may lead to a small number of cases of DDH that go
undiagnosed.
Due to the fact that there were many patients in this series
who were excluded due to the lack of hip imaging, we
cannot establish a true false-negative rate. Nevertheless, the
presence of any false-negative exam supports the need for
radiographic screening in this high-risk patient population.
Conclusion
There are a number of recommendations in the literature
for the screening of developmental dysplasia of the hip
(DDH), including those from the American Academy of
Pediatrics, the United States Preventative Services Task
Force, the American College of Radiology, and the Pedi-
atric Orthopaedic Society of North America. Recommen-
dations in these guidelines include risk factors such as
female gender, breech presentation, and a positive family
history, plus physical exam findings. None of these
guidelines address screening for DDH specifically in
patients with congenital muscular torticollis (CMT). There
is a clear association demonstrated in this and other series
between DDH and CMT. Given the fact that it is possible
for even an experienced examiner to miss DDH on physical
exam alone, we recommend either an ultrasound in patients
less than 6 months of age or an anteroposterior pelvis
radiograph in those over 6 months of age in this high-risk
population.
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